Relay Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Relay Therapeutics, Inc. (RLAY) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.120.140.150.280.45
Short-Term Investments0.660.610.850.680.23
Cash & Short-Term Investments0.780.141.000.280.45
Accounts Receivable0.000.000.010.000.08
Inventory0.000.000.000.000.00
Other Current Assets0.030.000.010.000.00
Total Current Assets0.810.771.020.980.77
Non-Current Assets
Property, Plant & Equipment (Net)0.060.070.080.030.03
Intangible Assets0.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.060.680.080.710.26
Total Assets0.870.841.101.010.80
Current Liabilities
Accounts Payable0.010.020.010.020.01
Short-Term Debt0.010.000.000.000.00
Accrued Liabilities0.020.010.020.010.01
Deferred Revenue0.010.000.000.000.00
Other Current Liabilities0.020.000.030.000.00
Total Current Liabilities0.050.030.060.020.01
Non-Current Liabilities
Long-Term Debt0.040.050.050.020.02
Other Non-Current Liabilities0.000.010.030.070.00
Total Non-Current Liabilities0.040.060.090.090.02
Total Liabilities0.090.090.150.110.04
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-1.74-1.40-1.06-0.77-0.40
Accumulated Other Comprehensive Income0.000.00-0.010.000.00
Additional Paid-in Capital2.522.152.021.671.17
Shares Outstanding0.170.130.120.110.00
Total Stockholders' Equity0.780.750.950.900.76
Total Liabilities & Equity0.870.841.101.010.80